Aurelium Biopharma Inc.
Records under this name other than patents Aurelium Biopharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Aurelium Biopharma Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,670,604 | Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease Lapsed on the fee record Ended Mar 2, 2014 · From the USPTO record | Lapsed on the fee record | Ended Mar 2, 2014 | From the USPTO record |
| US 7,662,580 | Tissue diagnostics for breast cancer Lapsed on the fee record Ended Feb 16, 2014 · From the USPTO record | Lapsed on the fee record | Ended Feb 16, 2014 | From the USPTO record |
| US 7,550,256 | Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease Lapsed on the fee record Ended Jun 23, 2013 · From the USPTO record | Lapsed on the fee record | Ended Jun 23, 2013 | From the USPTO record |
| US 7,413,851 | Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease Lapsed on the fee record Ended Aug 19, 2012 · From the USPTO record | Lapsed on the fee record | Ended Aug 19, 2012 | From the USPTO record |
| US 7,358,042 | Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease Lapsed on the fee record Ended Apr 15, 2012 · From the USPTO record | Lapsed on the fee record | Ended Apr 15, 2012 | From the USPTO record |
| US 7,226,748 | HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease Lapsed on the fee record Ended Jun 5, 2011 · From the USPTO record | Lapsed on the fee record | Ended Jun 5, 2011 | From the USPTO record |
| US 4,333,900 | Process for manufacture of high voltage transformers and the like Term ended Term ended no later than Jun 8, 2002 · Low confidence | Term ended | Term ended no later than Jun 8, 2002 | Low confidence |